Annual revenue:
$33.42B+$5.23B(+18.57%)Summary
- As of today (April 12, 2025), AMGN annual revenue is $33.42 billion, with the most recent change of +$5.23 billion (+18.57%) on December 31, 2024.
- During the last 3 years, AMGN annual revenue has risen by +$7.45 billion (+28.66%).
- AMGN annual revenue is now at all-time high.
Performance
AMGN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$9.09B+$583.00M(+6.86%)Summary
- As of today (April 12, 2025), AMGN quarterly revenue is $9.09 billion, with the most recent change of +$583.00 million (+6.86%) on December 31, 2024.
- Over the past year, AMGN quarterly revenue has increased by +$890.00 million (+10.86%).
- AMGN quarterly revenue is now at all-time high.
Performance
AMGN Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$33.42B+$890.00M(+2.74%)Summary
- As of today (April 12, 2025), AMGN TTM revenue is $33.42 billion, with the most recent change of +$890.00 million (+2.74%) on December 31, 2024.
- Over the past year, AMGN TTM revenue has increased by +$5.23 billion (+18.57%).
- AMGN TTM revenue is now at all-time high.
Performance
AMGN TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AMGN Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.6% | +10.9% | +18.6% |
| 3 y3 years | +28.7% | +32.7% | +28.7% |
| 5 y5 years | +43.1% | +46.6% | +39.5% |
AMGN Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.7% | at high | +48.8% | at high | +27.6% |
| 5 y | 5-year | at high | +43.1% | at high | +54.0% | at high | +39.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Amgen Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $33.42B(+18.6%) | $9.09B(+6.9%) | $33.42B(+2.7%) |
| Sep 2024 | - | $8.50B(+1.4%) | $32.53B(+5.2%) |
| Jun 2024 | - | $8.39B(+12.6%) | $30.93B(+4.7%) |
| Mar 2024 | - | $7.45B(-9.1%) | $29.53B(+4.8%) |
| Dec 2023 | $28.19B(+7.1%) | $8.20B(+18.7%) | $28.19B(+5.1%) |
| Sep 2023 | - | $6.90B(-1.2%) | $26.83B(+0.9%) |
| Jun 2023 | - | $6.99B(+14.4%) | $26.58B(+1.5%) |
| Mar 2023 | - | $6.11B(-10.7%) | $26.19B(-0.5%) |
| Dec 2022 | $26.32B(+1.3%) | $6.84B(+2.8%) | $26.32B(-0.0%) |
| Sep 2022 | - | $6.65B(+0.9%) | $26.33B(-0.2%) |
| Jun 2022 | - | $6.59B(+5.7%) | $26.38B(+0.3%) |
| Mar 2022 | - | $6.24B(-8.9%) | $26.32B(+1.3%) |
| Dec 2021 | $25.98B(+2.2%) | $6.85B(+2.1%) | $25.98B(+0.8%) |
| Sep 2021 | - | $6.71B(+2.8%) | $25.77B(+1.1%) |
| Jun 2021 | - | $6.53B(+10.6%) | $25.48B(+1.3%) |
| Mar 2021 | - | $5.90B(-11.0%) | $25.16B(-1.0%) |
| Dec 2020 | $25.42B(+8.8%) | $6.63B(+3.3%) | $25.42B(+1.7%) |
| Sep 2020 | - | $6.42B(+3.5%) | $24.99B(+2.8%) |
| Jun 2020 | - | $6.21B(+0.7%) | $24.30B(+1.4%) |
| Mar 2020 | - | $6.16B(-0.6%) | $23.97B(+2.6%) |
| Dec 2019 | $23.36B(-1.6%) | $6.20B(+8.0%) | $23.36B(-0.1%) |
| Sep 2019 | - | $5.74B(-2.3%) | $23.39B(-0.7%) |
| Jun 2019 | - | $5.87B(+5.7%) | $23.56B(-0.8%) |
| Mar 2019 | - | $5.56B(-10.8%) | $23.75B(+0.0%) |
| Dec 2018 | $23.75B(+3.9%) | $6.23B(+5.5%) | $23.75B(+1.8%) |
| Sep 2018 | - | $5.90B(-2.6%) | $23.32B(+0.6%) |
| Jun 2018 | - | $6.06B(+9.1%) | $23.19B(+1.1%) |
| Mar 2018 | - | $5.55B(-4.3%) | $22.94B(+0.4%) |
| Dec 2017 | $22.85B(-0.6%) | $5.80B(+0.5%) | $22.85B(-0.7%) |
| Sep 2017 | - | $5.77B(-0.6%) | $23.01B(-0.2%) |
| Jun 2017 | - | $5.81B(+6.3%) | $23.05B(+0.5%) |
| Mar 2017 | - | $5.46B(-8.4%) | $22.93B(-0.3%) |
| Dec 2016 | $22.99B(+6.1%) | $5.96B(+2.7%) | $22.99B(+1.9%) |
| Sep 2016 | - | $5.81B(+2.2%) | $22.56B(+0.4%) |
| Jun 2016 | - | $5.69B(+2.9%) | $22.47B(+1.4%) |
| Mar 2016 | - | $5.53B(-0.2%) | $22.16B(+2.3%) |
| Dec 2015 | $21.66B(+8.0%) | $5.54B(-3.3%) | $21.66B(+1.0%) |
| Sep 2015 | - | $5.72B(+6.6%) | $21.46B(+3.3%) |
| Jun 2015 | - | $5.37B(+6.7%) | $20.77B(+0.9%) |
| Mar 2015 | - | $5.03B(-5.6%) | $20.57B(+2.6%) |
| Dec 2014 | $20.06B(+7.4%) | $5.33B(+6.0%) | $20.06B(+1.6%) |
| Sep 2014 | - | $5.03B(-2.9%) | $19.74B(+1.5%) |
| Jun 2014 | - | $5.18B(+14.6%) | $19.46B(+2.6%) |
| Mar 2014 | - | $4.52B(-9.8%) | $18.96B(+1.5%) |
| Dec 2013 | $18.68B(+8.2%) | $5.01B(+5.5%) | $18.68B(+3.3%) |
| Sep 2013 | - | $4.75B(+1.5%) | $18.09B(+2.4%) |
| Jun 2013 | - | $4.68B(+10.4%) | $17.66B(+1.2%) |
| Mar 2013 | - | $4.24B(-4.1%) | $17.45B(+1.1%) |
| Dec 2012 | $17.27B(+10.8%) | $4.42B(+2.4%) | $17.27B(+2.7%) |
| Sep 2012 | - | $4.32B(-3.5%) | $16.82B(+2.3%) |
| Jun 2012 | - | $4.48B(+10.6%) | $16.44B(+3.3%) |
| Mar 2012 | - | $4.05B(+1.9%) | $15.92B(+2.2%) |
| Dec 2011 | $15.58B(+3.5%) | $3.97B(+0.7%) | $15.58B(+0.9%) |
| Sep 2011 | - | $3.94B(-0.4%) | $15.45B(+0.8%) |
| Jun 2011 | - | $3.96B(+6.8%) | $15.32B(+1.0%) |
| Mar 2011 | - | $3.71B(-3.5%) | $15.17B(+0.8%) |
| Dec 2010 | $15.05B(+2.8%) | $3.84B(+0.7%) | $15.05B(+0.2%) |
| Sep 2010 | - | $3.82B(+0.3%) | $15.02B(+0.0%) |
| Jun 2010 | - | $3.80B(+5.9%) | $15.02B(+0.6%) |
| Mar 2010 | - | $3.59B(-5.7%) | $14.93B(+1.9%) |
| Dec 2009 | $14.64B(-2.4%) | $3.81B(-0.1%) | $14.64B(+0.4%) |
| Sep 2009 | - | $3.81B(+2.7%) | $14.58B(-0.4%) |
| Jun 2009 | - | $3.71B(+12.2%) | $14.65B(-0.3%) |
| Mar 2009 | - | $3.31B(-11.8%) | $14.70B(-2.0%) |
| Dec 2008 | $15.00B(+1.6%) | $3.75B(-3.2%) | $15.00B(+0.0%) |
| Sep 2008 | - | $3.88B(+2.9%) | $15.00B(+1.8%) |
| Jun 2008 | - | $3.76B(+4.2%) | $14.73B(+0.2%) |
| Mar 2008 | - | $3.61B(-3.5%) | $14.70B(-0.5%) |
| Dec 2007 | $14.77B(+3.5%) | $3.75B(+3.7%) | $14.77B(-0.6%) |
| Sep 2007 | - | $3.61B(-3.1%) | $14.86B(-0.0%) |
| Jun 2007 | - | $3.73B(+1.1%) | $14.86B(+0.8%) |
| Mar 2007 | - | $3.69B(-3.9%) | $14.74B(+3.3%) |
| Dec 2006 | $14.27B(+14.8%) | $3.83B(+6.2%) | $14.27B(+4.1%) |
| Sep 2006 | - | $3.61B(+0.2%) | $13.70B(+3.5%) |
| Jun 2006 | - | $3.60B(+12.0%) | $13.25B(+3.4%) |
| Mar 2006 | - | $3.22B(-1.7%) | $12.81B(+3.1%) |
| Dec 2005 | $12.43B(+17.8%) | $3.27B(+3.7%) | $12.43B(+3.0%) |
| Sep 2005 | - | $3.15B(-0.6%) | $12.07B(+3.8%) |
| Jun 2005 | - | $3.17B(+12.0%) | $11.63B(+5.3%) |
| Mar 2005 | - | $2.83B(-2.6%) | $11.04B(+4.6%) |
| Dec 2004 | $10.55B | $2.91B(+7.2%) | $10.55B(+5.6%) |
| Sep 2004 | - | $2.71B(+5.0%) | $9.99B(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $2.58B(+10.3%) | $9.48B(+6.1%) |
| Mar 2004 | - | $2.34B(-0.1%) | $8.94B(+7.0%) |
| Dec 2003 | $8.36B(+51.3%) | $2.35B(+6.3%) | $8.36B(+7.5%) |
| Sep 2003 | - | $2.21B(+8.1%) | $7.78B(+10.0%) |
| Jun 2003 | - | $2.04B(+15.9%) | $7.07B(+14.1%) |
| Mar 2003 | - | $1.76B(-0.3%) | $6.20B(+13.8%) |
| Dec 2002 | $5.52B(+37.5%) | $1.77B(+17.8%) | $5.44B(+13.4%) |
| Sep 2002 | - | $1.50B(+28.2%) | $4.80B(+11.5%) |
| Jun 2002 | - | $1.17B(+15.9%) | $4.30B(+5.9%) |
| Mar 2002 | - | $1.01B(-10.3%) | $4.07B(+2.7%) |
| Dec 2001 | $4.02B(+16.5%) | $1.12B(+12.1%) | $3.96B(+5.8%) |
| Sep 2001 | - | $1.00B(+8.0%) | $3.74B(+2.8%) |
| Jun 2001 | - | $929.20M(+3.1%) | $3.64B(+1.7%) |
| Mar 2001 | - | $901.60M(-0.5%) | $3.58B(+2.5%) |
| Dec 2000 | $3.45B(+7.6%) | $905.80M(+0.3%) | $3.49B(+0.5%) |
| Sep 2000 | - | $902.90M(+4.0%) | $3.47B(+2.7%) |
| Jun 2000 | - | $867.90M(+6.6%) | $3.38B(+2.5%) |
| Mar 2000 | - | $814.10M(-8.4%) | $3.30B(+3.1%) |
| Dec 1999 | $3.20B(+21.3%) | $889.20M(+9.4%) | $3.20B(+5.2%) |
| Sep 1999 | - | $812.80M(+3.3%) | $3.05B(+4.6%) |
| Jun 1999 | - | $786.90M(+10.0%) | $2.91B(+5.3%) |
| Mar 1999 | - | $715.30M(-2.2%) | $2.77B(+4.8%) |
| Dec 1998 | $2.64B(+12.6%) | $731.60M(+7.6%) | $2.64B(+5.6%) |
| Sep 1998 | - | $680.20M(+6.1%) | $2.50B(+4.0%) |
| Jun 1998 | - | $641.10M(+8.8%) | $2.41B(+1.5%) |
| Mar 1998 | - | $589.40M(-0.4%) | $2.37B(+1.1%) |
| Dec 1997 | $2.35B(+6.7%) | $592.00M(+1.4%) | $2.35B(+0.4%) |
| Sep 1997 | - | $583.60M(-3.8%) | $2.34B(+1.2%) |
| Jun 1997 | - | $606.70M(+7.7%) | $2.31B(+2.0%) |
| Mar 1997 | - | $563.40M(-3.2%) | $2.26B(+2.9%) |
| Dec 1996 | $2.20B(+15.5%) | $582.10M(+4.6%) | $2.20B(+3.7%) |
| Sep 1996 | - | $556.40M(-0.8%) | $2.12B(+3.5%) |
| Jun 1996 | - | $560.90M(+12.5%) | $2.05B(+3.9%) |
| Mar 1996 | - | $498.70M(-1.1%) | $1.97B(+3.6%) |
| Dec 1995 | $1.90B(+17.5%) | $504.30M(+4.1%) | $1.90B(+3.8%) |
| Sep 1995 | - | $484.40M(+0.1%) | $1.83B(+3.7%) |
| Jun 1995 | - | $484.10M(+12.3%) | $1.77B(+4.5%) |
| Mar 1995 | - | $431.00M(-0.8%) | $1.69B(+4.4%) |
| Dec 1994 | $1.62B(+19.6%) | $434.30M(+3.8%) | $1.62B(+4.8%) |
| Sep 1994 | - | $418.60M(+2.7%) | $1.55B(+4.7%) |
| Jun 1994 | - | $407.40M(+13.3%) | $1.48B(+4.8%) |
| Mar 1994 | - | $359.70M(-0.0%) | $1.41B(+3.9%) |
| Dec 1993 | $1.35B(+25.4%) | $359.80M(+2.9%) | $1.35B(+4.3%) |
| Sep 1993 | - | $349.60M(+3.1%) | $1.30B(+4.0%) |
| Jun 1993 | - | $339.20M(+10.7%) | $1.25B(+7.0%) |
| Mar 1993 | - | $306.40M(+0.8%) | $1.17B(+8.1%) |
| Dec 1992 | $1.08B(+58.9%) | $304.00M(+1.4%) | $1.08B(+9.6%) |
| Sep 1992 | - | $299.90M(+16.4%) | $985.90M(+14.1%) |
| Jun 1992 | - | $257.60M(+17.7%) | $863.90M(+13.8%) |
| Mar 1992 | - | $218.80M(+4.4%) | $759.10M(+11.7%) |
| Dec 1991 | $679.80M(+78.3%) | $209.60M(+17.8%) | $679.80M(+21.1%) |
| Sep 1991 | - | $177.90M(+16.4%) | $561.40M(+21.4%) |
| Jun 1991 | - | $152.80M(+9.5%) | $462.30M(+21.3%) |
| Mar 1991 | - | $139.50M(+53.0%) | $381.20M(+27.6%) |
| Mar 1991 | $381.20M(+100.2%) | - | - |
| Dec 1990 | - | $91.20M(+15.7%) | $298.70M(+9.5%) |
| Sep 1990 | - | $78.80M(+9.9%) | $272.80M(+16.8%) |
| Jun 1990 | - | $71.70M(+25.8%) | $233.60M(+22.8%) |
| Mar 1990 | $190.40M(+171.2%) | $57.00M(-12.7%) | $190.30M(+30.8%) |
| Dec 1989 | - | $65.30M(+64.9%) | $145.50M(+43.3%) |
| Sep 1989 | - | $39.60M(+39.4%) | $101.50M(+24.8%) |
| Jun 1989 | - | $28.40M(+132.8%) | $81.30M(+15.8%) |
| Mar 1989 | $70.20M(+58.5%) | $12.20M(-42.7%) | $70.20M(+10.6%) |
| Dec 1988 | - | $21.30M(+9.8%) | $63.50M(+13.8%) |
| Sep 1988 | - | $19.40M(+12.1%) | $55.80M(+13.9%) |
| Jun 1988 | - | $17.30M(+214.5%) | $49.00M(+10.6%) |
| Mar 1988 | $44.30M(+48.7%) | $5.50M(-59.6%) | $44.30M(-8.3%) |
| Dec 1987 | - | $13.60M(+7.9%) | $48.30M(+13.6%) |
| Sep 1987 | - | $12.60M(0.0%) | $42.50M(+18.1%) |
| Jun 1987 | - | $12.60M(+32.6%) | $36.00M(+20.4%) |
| Mar 1987 | $29.80M(+41.2%) | $9.50M(+21.8%) | $29.90M(+12.0%) |
| Dec 1986 | - | $7.80M(+27.9%) | $26.70M(+11.3%) |
| Sep 1986 | - | $6.10M(-6.2%) | $24.00M(-5.5%) |
| Jun 1986 | - | $6.50M(+3.2%) | $25.40M(+17.6%) |
| Mar 1986 | $21.10M(+197.2%) | $6.30M(+23.5%) | $21.60M(+19.3%) |
| Dec 1985 | - | $5.10M(-32.0%) | $18.10M(+24.0%) |
| Sep 1985 | - | $7.50M(+177.8%) | $14.60M(+69.8%) |
| Jun 1985 | - | $2.70M(-3.6%) | $8.60M(+26.5%) |
| Mar 1985 | $7.10M(+153.6%) | $2.80M(+75.0%) | $6.80M(+44.7%) |
| Dec 1984 | - | $1.60M(+6.7%) | $4.70M(+51.6%) |
| Sep 1984 | - | $1.50M(+66.7%) | $3.10M(+93.8%) |
| Jun 1984 | - | $900.00K(+28.6%) | $1.60M(+128.6%) |
| Mar 1984 | $2.80M | $700.00K | $700.00K |
FAQ
- What is Amgen annual revenue?
- What is the all time high annual revenue for Amgen?
- What is Amgen annual revenue year-on-year change?
- What is Amgen quarterly revenue?
- What is the all time high quarterly revenue for Amgen?
- What is Amgen quarterly revenue year-on-year change?
- What is Amgen TTM revenue?
- What is the all time high TTM revenue for Amgen?
- What is Amgen TTM revenue year-on-year change?
What is Amgen annual revenue?
The current annual revenue of AMGN is $33.42B
What is the all time high annual revenue for Amgen?
Amgen all-time high annual revenue is $33.42B
What is Amgen annual revenue year-on-year change?
Over the past year, AMGN annual revenue has changed by +$5.23B (+18.57%)
What is Amgen quarterly revenue?
The current quarterly revenue of AMGN is $9.09B
What is the all time high quarterly revenue for Amgen?
Amgen all-time high quarterly revenue is $9.09B
What is Amgen quarterly revenue year-on-year change?
Over the past year, AMGN quarterly revenue has changed by +$890.00M (+10.86%)
What is Amgen TTM revenue?
The current TTM revenue of AMGN is $33.42B
What is the all time high TTM revenue for Amgen?
Amgen all-time high TTM revenue is $33.42B
What is Amgen TTM revenue year-on-year change?
Over the past year, AMGN TTM revenue has changed by +$5.23B (+18.57%)